Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaski

Showing results (191-200 of 1,307) with videos related to

Pageof 131
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2006
Microvascular dysfunction in cardiac syndrome X: the role of inflammationRamón Arroyo-Espliguero, Juan Carlos Kaski
European Cardiology|March 24, 2022
Ethnic and Regional Differences in the Management of Angina: The Way ForwardJack C Barton, Juan Carlos Kaski
Circulation|August 30, 2000
C-reactive protein as a clinical marker of riskJ C Kaski, X Garcia-Moll
European Heart Journal. Cardiovascular Pharmacotherapy|September 19, 2019
Cardiovascular pharmacotherapy: a new ESC Handbook comprehensively addresses pharmacological treatment issues for patients with cardiovascular diseaseJuan Carlos Kaski, Keld P Kjeldsen
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 25, 2004
Statistical model with a standard Gamma distributionMarco Patriarca, Anirban Chakraborti, Kimmo Kaski
European Heart Journal. Cardiovascular Pharmacotherapy|March 20, 2018
Trimetazidine: is there a role beyond angina?Jason M Tarkin, Juan Carlos Kaski
Medicina Clinica|December 6, 2006
[Diabetic miocardiopathy]Ignacio Gil-Ortega, Juan Carlos Kaski
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 17, 2013
Ischaemic heart disease in the ageing womanSofia A Papadopoulou, Juan Carlos Kaski
Expert Opinion on Biological Therapy|August 21, 2013
Evaluation of ASPIRE trial: a Phase III pivotal registration trial, using intracoronary administration of Generx (Ad5FGF4) to treat patients with recurrent angina pectorisJuan Carlos Kaski, Luciano Consuegra-Sanchez
Bioinformatics (Oxford, England)|August 28, 2014
Stronger findings for metabolomics through Bayesian modeling of multiple peaks and compound correlationsTommi Suvitaival, Simon Rogers, Samuel Kaski
Pageof 131

Showing results (191-200 of 1,307) with videos related to

Sort By:
Pageof 131
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2006
Microvascular dysfunction in cardiac syndrome X: the role of inflammationRamón Arroyo-Espliguero, Juan Carlos Kaski
European Cardiology|March 24, 2022
Ethnic and Regional Differences in the Management of Angina: The Way ForwardJack C Barton, Juan Carlos Kaski
Circulation|August 30, 2000
C-reactive protein as a clinical marker of riskJ C Kaski, X Garcia-Moll
European Heart Journal. Cardiovascular Pharmacotherapy|September 19, 2019
Cardiovascular pharmacotherapy: a new ESC Handbook comprehensively addresses pharmacological treatment issues for patients with cardiovascular diseaseJuan Carlos Kaski, Keld P Kjeldsen
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|August 25, 2004
Statistical model with a standard Gamma distributionMarco Patriarca, Anirban Chakraborti, Kimmo Kaski
European Heart Journal. Cardiovascular Pharmacotherapy|March 20, 2018
Trimetazidine: is there a role beyond angina?Jason M Tarkin, Juan Carlos Kaski
Medicina Clinica|December 6, 2006
[Diabetic miocardiopathy]Ignacio Gil-Ortega, Juan Carlos Kaski
Best Practice & Research. Clinical Obstetrics & Gynaecology|April 17, 2013
Ischaemic heart disease in the ageing womanSofia A Papadopoulou, Juan Carlos Kaski
Expert Opinion on Biological Therapy|August 21, 2013
Evaluation of ASPIRE trial: a Phase III pivotal registration trial, using intracoronary administration of Generx (Ad5FGF4) to treat patients with recurrent angina pectorisJuan Carlos Kaski, Luciano Consuegra-Sanchez
Bioinformatics (Oxford, England)|August 28, 2014
Stronger findings for metabolomics through Bayesian modeling of multiple peaks and compound correlationsTommi Suvitaival, Simon Rogers, Samuel Kaski
Pageof 131